Rojas C - Search Results

1

Ginkgo biloba Extract 761: A Review of Basic Studies and Potential Clinical Use in Psychiatric Disorders.

Montes P, Ruiz-Sanchez E, Rojas C, Rojas P. Montes P, et al. Among authors: rojas c, rojas p. CNS Neurol Disord Drug Targets. 2015;14(1):132-49. doi: 10.2174/1871527314666150202151440. CNS Neurol Disord Drug Targets. 2015. PMID: 25642989 Review.

2

Effect of a phytopharmaceutical medicine, Ginko biloba extract 761, in an animal model of Parkinson's disease: therapeutic perspectives.

Rojas P, Montes P, Rojas C, Serrano-García N, Rojas-Castañeda JC. Rojas P, et al. Among authors: rojas c, rojas castaneda jc. Nutrition. 2012 Nov-Dec;28(11-12):1081-8. doi: 10.1016/j.nut.2012.03.007. Epub 2012 Jul 17. Nutrition. 2012. PMID: 22817828 Review.

3

Antidepressant-like effect of a Ginkgo biloba extract (EGb761) in the mouse forced swimming test: role of oxidative stress.

Rojas P, Serrano-García N, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO, Rojas C. Rojas P, et al. Among authors: rojas c. Neurochem Int. 2011 Oct;59(5):628-36. doi: 10.1016/j.neuint.2011.05.007. Epub 2011 Jun 6. Neurochem Int. 2011. PMID: 21672588

4

EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity.

Rojas P, Rojas C, Ebadi M, Montes S, Monroy-Noyola A, Serrano-García N. Rojas P, et al. Among authors: rojas c. Neurochem Res. 2004 Jul;29(7):1417-23. doi: 10.1023/b:nere.0000026406.64547.93. Neurochem Res. 2004. PMID: 15202774

5

Ginkgo biloba pretreatment partially protects from the dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium.

Rojas P, Rojas-Castañeda J, Vigueras RM, Rojas C. Rojas P, et al. Among authors: rojas c, rojas castaneda j. Proc West Pharmacol Soc. 2000;43:87-8. Proc West Pharmacol Soc. 2000. PMID: 11056965 No abstract available.

6

Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.

Rojas P, Ruiz-Sánchez E, Rojas C, Ogren SO. Rojas P, et al. Among authors: rojas c. Neuroscience. 2012 Oct 25;223:246-57. doi: 10.1016/j.neuroscience.2012.08.004. Epub 2012 Aug 9. Neuroscience. 2012. PMID: 22885234

7

EGb761 blocks MPP+-induced lipid peroxidation in mouse corpus striatum.

Rojas P, Garduño B, Rojas C, Vigueras RM, Rojas-Castañeda J, Rios C, Serrano-Garcia N. Rojas P, et al. Among authors: rojas c, rojas castaneda j. Neurochem Res. 2001 Nov;26(11):1245-51. doi: 10.1023/a:1013971524150. Neurochem Res. 2001. PMID: 11874207

8

Reduction of zinc-positive terminal fields in striatum of mouse after 1-methyl-4-phenylpyridinium neurotoxicity.

Rojas P, Franco-Pérez JE, Rojas C, Rojas-Castañeda J, Ebadi M, Fernández-Valverde F, Serrano-García N. Rojas P, et al. Among authors: rojas c, rojas castaneda j. Neurotoxicology. 2005 Dec;26(6):959-68. doi: 10.1016/j.neuro.2005.04.007. Epub 2005 Jun 9. Neurotoxicology. 2005. PMID: 15950287

9

Prenatal ethanol exposure results in morphometrical alterations of immunoreactive neurons to vasopressin in the suprachiasmatic nucleus of young rats.

Rojas-Castañeda J, Rojas P, Vigueras RM, Reyes G, Rojas C. Rojas-Castañeda J, et al. Among authors: rojas c, rojas p. Proc West Pharmacol Soc. 2000;43:83-5. Proc West Pharmacol Soc. 2000. PMID: 11056964 No abstract available.

10

Neonatal exposure to monosodium glutamate induces morphological alterations in suprachiasmatic nucleus of adult rat.

Rojas-Castañeda JC, Vigueras-Villaseñor RM, Chávez-Saldaña M, Rojas P, Gutiérrez-Pérez O, Rojas C, Arteaga-Silva M. Rojas-Castañeda JC, et al. Among authors: rojas c, rojas p. Int J Exp Pathol. 2016 Feb;97(1):18-26. doi: 10.1111/iep.12157. Epub 2016 Jan 21. Int J Exp Pathol. 2016. PMID: 26799547 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results